《美股業績》寶潔(PG.US)上季多賺5% 遜預期
寶潔(PG.US)截至6月底止第四季盈利增長5%至30.52億美元,經調整後每股盈利為1.21美元,不及預期的1.22美元,這是公司5年來首次季度盈利遜預期。
上季收入增長3%至195.2億美元,優於市場預期的194.1億美元,因公司調高產品售價,從Crest至Old Spice等品牌的價格在季內平均上升約8%,而銷量僅減少約1%。
寶潔預計今財年自然收入增長介乎3%至5%,而上財年則超過7%,顯示消費者需求正在放緩。同時公司預計每股盈利為5.93美元,低於分析師預期的6.02美元,因美元走強以及商品與運費成本上漲將帶來33億美元的負面衝擊。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.